Apogee Therapeutics (APGE) Cash flow

363 Followers

Apogee Therapeutics Cash Flow

APGE's free cash flow for Q4 2025 was $-62.75M. For the 2025 fiscal year, APGE's free cash flow was decreased by $-60.27M and operating cash flow was $-62.69M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22
Operating Cash Flow	$ -227.45M	$ -171.17M	$ -74.76M	$ -16.43M
Investing Cash Flow	$ -179.57M	$ -300.46M	$ -273.91M	$ 0.00
Financing Cash Flow	$ 396.49M	$ 495.11M	$ 315.39M	$ 168.32M
End Cash Position	$ 131.55M	$ 142.08M	$ 118.61M	$ 151.89M
Free Cash Flow	$ -232.60M	$ -172.33M	$ -74.93M	$ -16.43M

Currency in USD